Sec Form 4 Filing - Lynch Jerome @ FOREST LABORATORIES INC - 2014-01-22

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Lynch Jerome 2. Issuer Name and Ticker or Trading Symbol FOREST LABORATORIES INC [ FRX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) SVP-Sales (Last) (First) (Middle) C/O FOREST LABORATORIES, INC., 909 THIRD AVENUE 3. Date of Earliest Transaction (MM/DD/YY) 01/22/2014 (Street) NEW YORK, NY10022 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 01/22/2014 M 15,000 A $ 42.535 81,577 ( 1 ) D Common Stock 01/22/2014 M 25,000 A $ 51.535 106,577 ( 1 ) D Common Stock 01/22/2014 M 12,500 A $ 37.255 119,077 ( 1 ) D Common Stock 01/22/2014 M 20,000 A $ 24.12 139,077 ( 1 ) D Common Stock 01/22/2014 M 12,000 A $ 31.265 151,077 ( 1 ) D Common Stock 01/22/2014 M 22,500 A $ 32.165 173,577 ( 1 ) D Common Stock 01/22/2014 M 22,700 A $ 29.995 196,277 ( 1 ) D Common Stock 01/22/2014 M 5,925 A $ 34.035 202,202 ( 1 ) D Common Stock 01/22/2014 S 135,625 D $ 67.2752 ( 2 ) 66,577 ( 1 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) $ 42.535 01/22/2014 M 15,000 12/13/2005 12/13/2014 Common Stock 15,000 ( 3 ) 0 D Stock Option (Right to Buy) $ 51.535 01/22/2014 M 25,000 12/07/2007 12/08/2016 Common Stock 25,000 ( 3 ) 0 D Stock Option (Right to Buy) $ 37.255 01/22/2014 M 12,500 12/06/2008 12/05/2017 Common Stock 12,500 ( 3 ) 0 D Stock Option (Right to Buy) $ 24.12 01/22/2014 M 20,000 12/08/2009 12/08/2018 Common Stock 20,000 ( 3 ) 0 D Stock Option (Right to Buy) $ 31.265 01/22/2014 M 12,000 12/07/2010 12/06/2019 Common Stock 12,000 ( 3 ) 8,000 D Stock Option (Right to Buy) $ 32.165 01/22/2014 M 22,500 12/06/2011 12/05/2020 Common Stock 22,500 ( 3 ) 27,500 D Stock Option (Right to Buy) $ 29.995 01/22/2014 M 22,700 12/05/2012 12/04/2021 Common Stock 22,700 ( 3 ) 22,700 D Stock Option (Right to Buy) $ 34.035 01/22/2014 M 5,925 05/07/2013 05/06/2022 Common Stock 5,925 ( 3 ) 17,775 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Lynch Jerome C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK, NY10022 SVP-Sales Signatures /s/ Rita Weinberger as attorney-in-fact for Jerome Lynch 01/24/2014 Signature of Reporting Person Date

Explanation of Responses:

( 1 )This amount includes shares of common stock which are subject to a risk of forfeiture. ( 2 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.66, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. ( 3 )Not Applicable.

Remarks: Exhibit List: Exhibit 24 - Power of Attorney

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.